What are the appropriate thresholds for High Quality Performance Indicators for breast surgery in Australia and New Zealand? [0.03%]
澳大利亚和新西兰乳腺手术高质量绩效指标的适当阈值是什么？
Shehnarz Salindera,Michelle Ogilvy,Andrew Spillane
Shehnarz Salindera
Aim: To evaluate BreastSurgANZ members' compliance at various threshold rates for 4 evaluable High-Quality Performance Indicators (HQPIs) introduced to improve patient care. To benchmark global best practice to assist in ...
Reduced symptom burden with the support of an interactive app during neoadjuvant chemotherapy for breast cancer - A randomized controlled trial [0.03%]
一种互动式应用程序支持下的乳腺癌新辅助化疗减症控病临床试验
Maria Fjell,Ann Langius-Eklöf,Marie Nilsson et al.
Maria Fjell et al.
Objectives: Neoadjuvant chemotherapy causes distressing symptoms, which have to be managed by patients at home. Assessing and acting upon relevant patient-reported symptoms regularly with the support of mHealth such as ap...
Randomized Controlled Trial
Breast (Edinburgh, Scotland). 2020 Jun:51:85-93. DOI:10.1016/j.breast.2020.03.004 2020
Laura Biganzoli,Fatima Cardoso,Marc Beishon et al.
Laura Biganzoli et al.
This article is an update of the requirements of a specialist breast centre, produced by EUSOMA and endorsed by ECCO as part of Essential Requirements for Quality Cancer Care (ERQCC) programme, and ESMO. To meet aspirations for comprehensiv...
Practice Guideline
Breast (Edinburgh, Scotland). 2020 Jun:51:65-84. DOI:10.1016/j.breast.2020.02.003 2020
Tzu-Chun Chou,Shao-Chin Chiang,Yu Ko
Tzu-Chun Chou
Background: New developments in medications for metastatic breast cancer (MBC) can be of great benefit to patients, but unfortunately these medicines also increase expenditures. Cost-utility analyses (CUAs) are needed to ...
The effect of post mastectomy radiation therapy on survival in breast cancer patients with N1mic disease [0.03%]
乳房微小转移(N1mic)乳腺癌患者保乳术后不同放疗模式的疗效分析
Mausam Patel,Chenghui Li,Julia H Aronson et al.
Mausam Patel et al.
Background: The role of post mastectomy radiation therapy (PMRT) in patients with N1mic breast cancer has not been well defined. A retrospective analysis was performed using the SEER database to evaluate the impact of PMR...
The survival benefit of postmastectomy radiotherapy for breast cancer patients with T1-2N1 disease according to molecular subtype [0.03%]
根据分子分型，乳房肿瘤切术后辅助放射治疗对T1-2N1乳腺癌患者的生存收益分析
Jinli Wei,Yizhou Jiang,Zhimin Shao
Jinli Wei
Objective: To evaluate the significance of postmastectomy radiotherapy (PMRT) in female breast cancer patients with T1-2N1M0 disease according to molecular subtypes and other risk factors. ...
Dual HER2 blockade in the first-line treatment of metastatic breast cancer - A retrospective population-based observational study in Danish patients [0.03%]
丹麦患者一线治疗转移性乳腺癌的双HER2阻断疗法——一项基于人口的回顾性观察研究
Thomas Christensen,Tobias Berg,Lise Birk Nielsen et al.
Thomas Christensen et al.
Objectives: Randomized clinical trials do not include a population that truly reflects a real-world population, due to their inclusion and exclusion criteria. This leads to concerns about the applicability of these studie...
Observational Study
Breast (Edinburgh, Scotland). 2020 Jun:51:34-39. DOI:10.1016/j.breast.2020.03.002 2020
Evaluation of 2014 margin guidelines on re-excision and recurrence rates after breast conserving surgery: A multi-institution retrospective study [0.03%]
评估2014年切缘指南对乳腺癌保乳手术后重新切除率和复发率的影响：一项多中心回顾性研究
Anne Kuritzky,Chantal Reyna,Kandace P McGuire et al.
Anne Kuritzky et al.
Introduction: A 2014 consensus statement from the Society of Surgical Oncology and American Society for Radiation Oncology supported "no ink on tumor" as an adequate margin for breast conserving therapy (BCT). This study ...
Multicenter Study
Breast (Edinburgh, Scotland). 2020 Jun:51:29-33. DOI:10.1016/j.breast.2020.02.013 2020
Patient factors associated with discrepancies between patient-reported and clinician-documented peripheral neuropathy in women with breast cancer receiving paclitaxel: A pilot study [0.03%]
与乳腺癌患者在接受紫杉醇治疗期间报告的及临床医生记录的外周神经病变差异相关的患者因素：一项初步研究
Teresa M Salgado,Jin Liu,Holly L Reed et al.
Teresa M Salgado et al.
Purpose: Discrepancies between clinicians' assessment of chemotherapy-induced peripheral neuropathy (CIPN) and patient-reported outcomes (PRO) have been described, though the underlying reasons are unknown. Our objective ...
Observational Study
Breast (Edinburgh, Scotland). 2020 Jun:51:21-28. DOI:10.1016/j.breast.2020.02.011 2020